3-iodobenzylguanidine has been researched along with Meningeal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhurst, TJ; Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
| Argov, S; Lantsberg, S; Liel, Y; Zirkin, HJ; Zucker, G | 1 |
| Buisseret, T; Caemaert, J; DeGeeter, F; Deleu, D; Ebinger, G; Goossens, A | 1 |
3 other study(ies) available for 3-iodobenzylguanidine and Meningeal Neoplasms
| Article | Year |
|---|---|
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Dura Mater; Etoposide; Femur; Humans; Infant; Iodine Radioisotopes; Male; Meningeal Neoplasms; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Remission Induction; Skin Neoplasms | 2009 |
Malignant pheochromocytoma simulating meningioma: coexistence of recurrent meningioma and metastatic pheochromocytoma in the base of the skull.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Diagnosis, Differential; Follow-Up Studies; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pheochromocytoma; Skull Base Neoplasms; Time Factors; Tomography, X-Ray Computed | 2002 |
Dural metastasis from laryngeal malignant carcinoid.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Dura Mater; Humans; Iodine Radioisotopes; Iodobenzenes; Laryngeal Neoplasms; Male; Meningeal Neoplasms; Middle Aged; Radionuclide Imaging | 1989 |